Mar 17, 2023 | In the News, Uncategorized
New Heritage exits its investment in Rhythmlink, the market-leading designer and manufacturer of single-use brain health and neurodiagnostic electrodes. New Heritage first invested in Rhythmlink in February 2019 and sold the Company to Graham Partners after successfully executing a strategic and operational growth plan that sets up Rhythmlink for continued expansion. GroveStreet first become a New Heritage LP in 2014. Read more about the deal here: https://www.newheritagecapital.com/new-heritage-capital-exits-investment-in-portfolio-company-rhythmlink/
Mar 17, 2023 | GroveStreet, In the News
KPS Capital Partners (KPS) completes the sale of Howden, a leading global provider of mission critical air and gas handling products and services, to Chart Industries for $4.4B in cash. The strategic acquisition expands Chart’s offering across clean power, water, food and industrials. KPS first invested in Howden in September 2019. GroveStreet first became a KPS LP in 2003. Read more about the deal here: https://www.globenewswire.com/news-release/2023/03/17/2629484/0/en/Chart-Industries-Completes-the-Acquisition-of-Howden.html
Mar 1, 2023 | GroveStreet, In the News
La Jolla, California – Managing Partner Bruce Ou led a discussion about investment opportunities in biotech at the PPI Winter Roundtable with venture investor Rachel Lane, Ph. D. of Versant, biotech entrepreneur Enoch Kariuki, and Morgan Stanley’s Head of Biotech Research, Matthew Harrison. Watch a summary of the discussion below.
